Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor

Curr Probl Surg. 2003 Mar;40(3):144-93. doi: 10.1067/msg.2003.022223.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Benzamides
  • Biopsy, Needle
  • Chemotherapy, Cancer, Regional Perfusion / methods*
  • Enzyme Inhibitors / administration & dosage*
  • Enzyme Inhibitors / adverse effects
  • Female
  • Gastrointestinal Neoplasms / drug therapy*
  • Gastrointestinal Neoplasms / genetics
  • Gastrointestinal Neoplasms / mortality
  • Gastrointestinal Neoplasms / pathology*
  • Humans
  • Imatinib Mesylate
  • Immunohistochemistry
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Male
  • Neoplasm Staging
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / secondary
  • Piperazines / administration & dosage*
  • Piperazines / adverse effects
  • Prognosis
  • Pyrimidines / administration & dosage*
  • Pyrimidines / adverse effects
  • Randomized Controlled Trials as Topic
  • Sensitivity and Specificity
  • Stromal Cells / pathology*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Benzamides
  • Enzyme Inhibitors
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate